Suppr超能文献

甲状腺功能减退症与痴呆风险增加:一项丹麦全国范围内基于登记的研究。

Increased risk of dementia in hypothyroidism: A Danish nationwide register-based study.

机构信息

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.

Department of Endocrinology, Odense University Hospital, Odense, Denmark.

出版信息

Clin Endocrinol (Oxf). 2021 Jun;94(6):1017-1024. doi: 10.1111/cen.14424. Epub 2021 Jan 31.

Abstract

OBJECTIVE

Globally, the prevalence of individuals with dementia is increasing, and identification of risk factors is of paramount interest. Using population-based registers, we evaluated whether hypothyroidism is a risk factor for dementia.

DESIGN

Register-based cohort study.

PATIENTS AND METHODS

Risk of dementia was evaluated in two cohorts. The DNPR cohort comprises 111,565 hypothyroid patients, diagnosed between 1995 and 2012, and 446,260 euthyroid age- and sex-matched individuals (median follow-up 6.2 years). The OPENTHYRO cohort comprises 233,844 individuals with at least one measurement of serum thyrotropin (TSH) between 1995 and 2011, of whom 2,894 had hypothyroidism (median follow-up 7.2 years). Primary outcome was dementia defined as an International Classification of Diseases 10 code, or prescription of medicine for dementia.

RESULTS

In the DNPR cohort, risk of dementia was significantly increased in subjects with hypothyroidism (HR 1.22; 95% CI: 1.17-1.27), which attenuated after adjusting for pre-existing comorbidity (HR 0.82; 95% CI: 0.79-0.86). Stratification of age into ≤56 and >56 years showed an inverse relationship between age and risk of dementia (HR 2.03; 95% CI: 1.62-2.53 and HR . 1.00; 95% CI: 0.96-1.05). In the OPENTHYRO cohort, the risk of dementia was significantly increased for each 6 months of elevated TSH (HR 1.12; 95% CI: 1.07-1.16).

CONCLUSIONS

Hypothyroidism is associated with increased risk of dementia. The association is influenced by comorbidity and age. Every 6 months of elevated TSH increased the risk of dementia by 12%, suggesting that also the length of hypothyroidism influences the risk of dementia.

摘要

目的

全球范围内,痴呆症患者的患病率正在上升,因此确定风险因素至关重要。本研究利用基于人群的登记系统,评估了甲状腺功能减退是否是痴呆症的一个风险因素。

设计

基于登记的队列研究。

患者和方法

本研究评估了两个队列中痴呆症的风险。DNPR 队列包括 111565 名 1995 年至 2012 年间诊断为甲状腺功能减退的患者和 446260 名年龄和性别与之匹配的甲状腺功能正常者(中位随访时间 6.2 年)。OPENTHYRO 队列包括 233844 名 1995 年至 2011 年间至少有一次血清促甲状腺激素(TSH)测量值的患者,其中 2894 名患有甲状腺功能减退(中位随访时间 7.2 年)。主要结局为国际疾病分类第 10 版定义的痴呆症,或痴呆症药物处方。

结果

在 DNPR 队列中,甲状腺功能减退患者痴呆症的风险显著增加(HR 1.22;95%CI:1.17-1.27),但在校正了既往合并症后风险降低(HR 0.82;95%CI:0.79-0.86)。将年龄分为≤56 岁和>56 岁后,年龄与痴呆症风险之间呈反比关系(HR 2.03;95%CI:1.62-2.53 和 HR 1.00;95%CI:0.96-1.05)。在 OPENTHYRO 队列中,TSH 升高每增加 6 个月,痴呆症的风险显著增加(HR 1.12;95%CI:1.07-1.16)。

结论

甲状腺功能减退与痴呆症风险增加相关。这种关联受合并症和年龄的影响。TSH 升高每增加 6 个月,痴呆症的风险增加 12%,这表明甲状腺功能减退的持续时间也会影响痴呆症的风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验